![Christopher Dinsmore](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Dinsmore
Corporate Officer/Principal bei
Stablix, Inc.
Profil
Christopher Dinsmore currently works at Wisconsin Alumni Research Foundation, as Advisor and Stablix, Inc., as Scientific Advisory.
Dr. Dinsmore also formerly worked at Merck & Co., Inc., as Executive Director-Discovery Chemistry, Forma Therapeutics, Inc., as VP-Medicinal & Computational Chemistry from 2014 to 2019, Third Rock Ventures LLC, as Entrepreneur-Residence from 2019 to 2020, Kronos Bio, Inc., as Chief Scientific Officer from 2020 to 2024, and Third Harmonic Bio, Inc., as Chief Scientific Officer from 2024 to 2025.
Dr. Dinsmore received his undergraduate degree from Bowdoin College and doctorate degree from the University of Minnesota.
Aktive Positionen von Christopher Dinsmore
| Unternehmen | Position | Beginn |
|---|---|---|
Stablix, Inc.
 Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical stage biotechnology company, which pioneering small molecule medicines for targeted protein stabilization | Corporate Officer/Principal | - |
Wisconsin Alumni Research Foundation
 Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Provides research patenting and licensing services | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Christopher Dinsmore
| Unternehmen | Position | Ende |
|---|---|---|
| THIRD HARMONIC BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 21.04.2025 |
| KRONOS BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 16.02.2024 |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Corporate Officer/Principal | 02.06.2020 |
Forma Therapeutics, Inc.
 Forma Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer and other genetically driven diseases | Corporate Officer/Principal | 01.06.2019 |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Ausbildung von Christopher Dinsmore
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
33
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Forma Therapeutics, Inc.
Forma Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer and other genetically driven diseases | Health Technology |
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Provides research patenting and licensing services | Commercial Services |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Finance |
Kronos Bio, Inc.
 Kronos Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cancer therapeutics | Health Technology |
Third Harmonic Bio, Inc.
 Third Harmonic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of allergic and immune diseases and disorders | Health Technology |
Stablix, Inc.
Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical stage biotechnology company, which pioneering small molecule medicines for targeted protein stabilization | Commercial Services |
Wählen Sie MarketScreener 
